Other official information and services: www.belgium.be  Logo Belgium

Non-steroidal anti-inflammatory drugs (NSAID)

Key figures

PRESCRIBERS
Main prescribers: General practitioners 71.81%
INSURED CONSUMERS
% of insured consumers 23.65%
Median age 50 years
Max/min ratio of the median age (by district) 1.06
Percentage of women 54.84%
Ratio Preferential scheme/General scheme 1.07
Coefficient of variation (2023) 11.19
Max/min ratio of % of insured consumers (by district) 1.58
CONSUMPTION
Annual consumption (DDD) 129,982,414
Consumption of DDD (per 100,000 insured persons) 1,128,270.10
% DDD issued outside the insurance (approximate) 32.69%
Average annual consumption per insured consumer (DDD) 47.70
% of insured consumers with > 3 times the average consumption 4,87%
Coefficient of variation 2013-2015 9.79
Coefficient of variation 2021-2023 17.81
Trend 2013-2023 -2.25%
Trend 2013-2021 -2.97%
Trend 2021-2023 0.66%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance 37,655,968 €
Average annual expenditure per insured person 3.27 €
Average patient share per insured consumer 13.27%
Max/min ratio of expenditure per insured person (by disctrict) 1.85
% “Low-cost” medication 87.00%
Trend 2013-2023 -3.84%
Trend 2021-2023 2.54%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on a yellow background, otherwise on a grey background.

Download the full report

Download the methodology